Interleukin-33, friend and foe in type-2 immune responses.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Opinion in Immunology

• Publication date

  2016-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.coi.2016.05.004PMID 27254379
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa

  2016cited by this paper
• LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

  2015cited by this paper
• Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation

  2015cited by this paper
• IL‐33 induces Egr‐1‐dependent TSLP expression via the MAPK pathways in human keratinocytes

  2015cited by this paper
• A single-nucleotide polymorphism in the interleukin-1 receptor-associated protein gene is associated with impaired glucose regulation and type 2 diabetes in a case-controlled study.

  2015cited by this paper
• Myocardial pressure overload induces systemic inflammation through endothelial cell IL-33

  2015cited by this paper
• The Deubiquitinase USP17 Regulates the Stability and Nuclear Function of IL-33

  2015cited by this paper
• Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.

  2015cited by this paper
• The Alarmin IL-33 Promotes Regulatory T Cell Function in the Intestine

  2014cited by this paper
• IL-25-responsive, lineage-negative KLRG1hi cells are multipotential “inflammatory” type 2 innate lymphoid cells

  2014cited by this paper
• Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension.

  2014cited by this paper
• IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

  2014cited by this paper
• Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells

  2014cited by this paper
• Linking acute infection to chronic lung disease. The role of IL-33-expressing epithelial progenitor cells.

  2014cited by this paper
• IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut☆

  2014cited by this paper
• Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations

  2014cited by this paper
• A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis

  2013cited by this paper
• Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

  2013cited by this paper
• Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease

  2013cited by this paper
• Decoding asthma: translating genetic variation in IL33 and IL1RL1 into disease pathophysiology.

  2013cited by this paper
• Interleukin‐33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE‐mediated airway inflammation and remodelling in mice

  2013cited by this paper
• Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice

  2013cited by this paper
• IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

  2013cited by this paper
• Structural insights into the interaction of IL-33 with its receptors

  2013cited by this paper
• IL-33 promotes Staphylococcus aureus-infected wound healing in mice.

  2013cited by this paper
• Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation

  2013cited by this paper
• Transcription factor IRF 4 drives dendritic cells to promote Th 2 differentiation

  2013cited by this paper
• Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation*

  2013cited by this paper
• Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain

  2012cited by this paper
• IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

  2012cited by this paper
• Trichostrongylus colubriformis larvae induce necrosis and release of IL33 from intestinal epithelial cells in vitro: implications for gastrointestinal nematode vaccine design.

  2012cited by this paper
• Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists

  2012cited by this paper
• IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors.

  2012cited by this paper
• Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion

  2012cited by this paper
• The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses

  2012cited by this paper
• Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation

  2012cited by this paper
• Regulation of IL-33 expression by IFN-γ and tumor necrosis factor-α in normal human epidermal keratinocytes.

  2012cited by this paper
• Regulation of interleukin‐33 and thymic stromal lymphopoietin in human nasal fibroblasts by proinflammatory cytokines

  2012cited by this paper
• Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.

  2012cited by this paper
• Anti‐IL‐33 antibody has a therapeutic effect in a murine model of allergic rhinitis

  2012cited by this paper
• Interleukin-33 Ameliorates Experimental Colitis through Promoting Th2/Foxp3+ Regulatory T-Cell Responses in Mice

  2012cited by this paper
• Inducible IL-33 Expression by Mast Cells Is Regulated by a Calcium-Dependent Pathway

  2012cited by this paper
• Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells*

  2012cited by this paper
• Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice

  2012cited by this paper
• IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation

  2012cited by this paper
• A critical role of IL-33 in experimental allergic rhinitis.

  2012cited by this paper
• IL‐33 induces skin inflammation with mast cell and neutrophil activation

  2011cited by this paper
• Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection

  2011cited by this paper
• The Danger Signal, Extracellular ATP, Is a Sensor for an Airborne Allergen and Triggers IL-33 Release and Innate Th2-Type Responses

  2011cited by this paper
• The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation.

  2011cited by this paper
• Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus

  2011cited by this paper
• Infection with influenza virus induces IL-33 in murine lungs.

  2011cited by this paper
• Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity

  2011cited by this paper
• Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis

  2010cited by this paper
• Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity

  2010cited by this paper
• IL-33 is a crucial amplifier of innate rather than acquired immunity

  2010cited by this paper
• Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

  2010cited by this paper
• IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy

  2010cited by this paper
• Expression and regulation of interleukin‐33 in human monocytes

  2010cited by this paper
• The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1

  2009cited by this paper
• IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation1

  2009cited by this paper
• Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage*

  2009cited by this paper
• Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

  2009cited by this paper
• Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1

  2009cited by this paper
• Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.

  2009cited by this paper
• Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

  2009cited by this paper
• Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

  2009cited by this paper
• Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.

  2009cited by this paper
• Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.

  2008cited by this paper
• IL-33 induced Ag-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4

  2008cited by this paper
• IL-33 exacerbates antigen-induced arthritis by activating mast cells

  2008cited by this paper
• IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-41

  2008cited by this paper
• The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

  2008cited by this paper
• Molecular mimicry between IL‐33 and KSHV for attachment to chromatin through the H2A–H2B acidic pocket

  2008cited by this paper
• IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.

  2008cited by this paper
• Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation*

  2007cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation.

  2007cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005influential reference
• Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation.

  2005cited by this paper
• Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.

  2005cited by this paper
• Expression and Regulation of ST 2 , an Interleukin-1 Receptor Family Member , in Cardiomyocytes and Myocardial Infarction

  2002cited by this paper
• Expression and Regulation of ST2, an Interleukin-1 Receptor Family Member, in Cardiomyocytes and Myocardial Infarction

  2002cited by this paper
• Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V.

  2001cited by this paper
• T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses

  2000cited by this paper
• Mechanisms of allergy and clinical immunology IL-33 , but not thymic stromal lymphopoietin or IL-25 , is central to mite and peanut allergic sensitization

  year unknowncited by this paper

• Assessment of Interleukin-33 Levels in Patients with Familial Mediterranean Fever

  2026cites this paper
• Constitutively high levels of endogenous soluble ST2 inhibit food allergic responses in mice.

  2026cites this paper
• IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential

  2025cites this paper
• Interleukin-33 in cutaneous wound healing

  2025cites this paper
• Physiopathology of Allergic Asthma: A Comprehensive Review

  2025cites this paper
• BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial

  2025cites this paper
• Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease

  2025cites this paper
• The Effect and Mechanism of IL-33 on Decidual Immune Cell Function at Maternal-Fetal Interface

  2025cites this paper
• Endogenous IL-33 inhibits apoptosis in non-small cell lung cancer cells by regulating BCL2/BAX via the ERK1/2 pathway

  2025cites this paper
• Evaluation of Serum Interleukin-33 Level in Iraqi Patients with and without Periodontal Disease

  2024cites this paper
• Is There Any Difference in the In Situ Immune Response in Active Localized Cutaneous Leishmaniasis That Respond Well or Poorly to Meglumine Antimoniate Treatment or Spontaneously Heal?

  2023cites this paper
• Knowledge mapping of interleukin-33: a bibliometric study.

  2023cites this paper
• The implication of infection with respiratory syncytial virus in pediatric recurrent wheezing and asthma: knowledge expanded post-COVID-19 era

  2023cites this paper
• Interleukin-33 as a Potential Therapeutic Target in Gastric Cancer Patients: Current Insights

  2023cites this paper
• Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells

  2022cites this paper
• The Role of Airway Epithelial Cell Alarmins in Asthma

  2022cites this paper
• Nematode ascarosides attenuate mammalian type 2 inflammatory responses

  2022cites this paper
• Regulation of Peripheral Inflammation by a Non-Viable, Non-Colonizing Strain of Commensal Bacteria

  2022cites this paper
• Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential

  2022cites this paper
• Sounding the alarmins—The role of alarmin cytokines in asthma

  2022cites this paper
• IL-33 biology in cancer: An update and future perspectives.

  2022cites this paper
• The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy.

  2021cites this paper
• The role of the immune response in the etiopathogenesis of endometriosis

  2021cites this paper
• Biological Therapies for Atopic Dermatitis: A Systematic Review

  2021cites this paper
• The role of MerTK in promoting cell migration is enhanced by the oncogenic Ras/IL‐33 signaling axis

  2021cites this paper
• T helper 17 cell-related cytokines in serum and saliva during management of periodontitis.

  2020cites this paper
• Research status and progress of laboratory indexes related to neuromyelitis optica spectrum disorders

  2020cites this paper
• Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage

  2020cites this paper
• IL-33/ST2 induces neutrophil-dependent reactive oxygen species production and mediates gout pain

  2020cites this paper
• Emerging Roles of Interleukin-33-responsive Kidney Group 2 Innate Lymphoid Cells in Acute Kidney Injury

  2020cites this paper
• Nasal Epithelial Cells Activated with Alternaria and House Dust Mite Induce Not Only Th2 but Also Th1 Immune Responses

  2020cites this paper
• Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors

  2020cites this paper
• IL-33 Induces Type-2-Cytokine Phenotype but Exacerbates Cardiac Remodeling Post-Myocardial Infarction with Eosinophil Recruitment, Worsened Systolic Dysfunction, and Ventricular Wall Rupture.

  2020cites this paper
• Resveratrol reverses the effect of TNF-α on inflammatory markers in a model of autoimmune uveitis

  2020cites this paper
• The Prostaglandin D2 Receptor CRTH2 Promotes IL-33–Induced ILC2 Accumulation in the Lung

  2020influential citation
• Increased Type 2 Innate Lymphoid Cells in Patients with Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome.

  2019cites this paper
• Interleukin (IL)-33 and the IL-1 Family of Cytokines-Regulators of Inflammation and Tissue Homeostasis.

  2019cites this paper
• Low levels of vitamin D and the relationship between vitamin D and Th2 axis-related cytokines in neuromyelitis optica spectrum disorders.

  2019cites this paper
• Elevated expression of interleukin-33 in myasthenia gravis patients.

  2019cites this paper
• Interleukin‐33 in the developing lung—Roles in asthma and infection

  2019cites this paper
• Interleukin 1 Receptor-Like 1 (IL1RL1) Promotes Airway Bacterial and Viral Infection and Inflammation

  2019cites this paper
• Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis

  2019cites this paper
• Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis

  2019influential citation
• The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox

  2019cites this paper
• Influence of IL‐6, IL‐33, and TNF‐α on human mast cell activation: Lessons from single cell analysis by flow cytometry

  2018cites this paper
• Role of the IL-33/ST2L axis in colorectal cancer progression.

  2018cites this paper
• Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer

  2018cites this paper
• Th2 axis‐related cytokines in patients with neuromyelitis optica spectrum disorders

  2018cites this paper
• IL-33/ST2 axis mediates hyperplasia of intrarenal urothelium in obstructive renal injury

  2018cites this paper
• A network map of IL-33 signaling pathway

  2018cites this paper
• The Role of IL-33/ST2 Pathway in Tumorigenesis

  2018cites this paper
• Increased serum interleukin-33 concentrations predict worse prognosis of aneurysmal subarachnoid hemorrhage.

  2018cites this paper
• Soluble ST2 suppresses IL-5 production by human basophilic KU812 cells, induced by epithelial cell-derived IL-33.

  2018cites this paper
• Immune markers and proteasomal gene polymorphisms specific for asthma phenotypes

  2018cites this paper
• Effects of 1,25‐dihydroxyvitamin D3 in an ovalbumin‐induced allergic rhinitis model

  2017cites this paper
• Biologic Treatments Targeted to Innate Cytokines

  2017cites this paper
• Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation

  2017cites this paper
• Interleukin-33 plasma levels in patients with relapsing-remitting multiple sclerosis

  2017cites this paper
• IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model

  2017cites this paper
• Understanding Interleukin 33 and Its Roles in Eosinophil Development

  2017cites this paper
• Allergic airway inflammation: key players beyond the Th2 cell pathway

  2017cites this paper
• Cytokines as therapeutic targets in primary Sjögren syndrome

  2017cites this paper
• Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease

  2017cites this paper
• Th2 and Th1 Responses: Clear and Hidden Sides of Immunity Against Intestinal Helminths.

  2017cites this paper
• Endogenous prostaglandin E2 amplifies IL-33 production by macrophages through an E prostanoid (EP)2/EP4-cAMP-EPAC-dependent pathway

  2017cites this paper
• TGF-β1 Suppresses IL-33–Induced Mast Cell Function

  2017cites this paper
• Emerging Roles of IL-33/ST2 Axis in Renal Diseases

  2017cites this paper
• IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice.

  2017cites this paper
• IL-33 signaling fuels outgrowth and metastasis of human lung cancer.

  2016cites this paper
• Translational studies of viral-induced asthma and COPD exacerbations

  2016cites this paper
• Temporal Regulation by Innate Type 2 Cytokines in Food Allergies

  2016cites this paper
• IL-9-producing cells in the development of IgE-mediated food allergy

  2016cites this paper
• T cells in kidney injury and regeneration

  year unknowncites this paper